Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
No Study Results Posted
First in Human Study of ALS-002158; Single Dose, Food Effect in Healthy Volunteers; Multiple Doses in Chronic Hepatitis C Genotype 1
This study has been terminated.
( ALS-2158 showed insufficient antiviral activity to warrant proceeding with further clinical development. )
Study NCT01554085 Information provided by Alios Biopharma Inc.
First Received on March 12, 2012. Last Updated on September 26, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Hepatitis C, Chronic
Additional conditions recognized in this trial
More general conditions related to this trial
Digestive System Diseases
Hepatitis, Viral, Human
RNA Virus Infections
Interventions listed in this trial
Sponsors listed in this trial
Alios Biopharma Inc.
Vertex Pharmaceuticals Incorporated
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers